a month ago
VKTX
AnalystsRoger SongRoger Song's Stock Forecasts
AnalystsRoger Song
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4359 out of 4554 analysts
Average Return
-24.54%
Win Rate
18%3 out of 17
Risk vs Reward
Poor
Good
Roger Song's 5 best and worst ratings
Roger Song Analyst Color
Get additional color on Roger Song's coverage of popular stocks
Roger Song's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvalent IncNUVL | 1 | Strong Buy | $97.00 | +53.82% | Initiates Coverage On | 2 days ago |
Tourmaline Bio IncTRML | 2 | Strong Buy | $72.00 | +359.77% | Maintains | a month ago |
Viking Therapeutics IncVKTX | 1 | Strong Buy | $110.00 | +70.09% | Initiates Coverage On | a month ago |
Nektar TherapeuticsNKTR | 4 | Hold | $1.00 | -24.24% | Maintains | a month ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $2.00 | -24.53% | Maintains | 7 months ago |
Igm Biosciences IncIGMS | 1 | Strong Buy | $55.00 | N/A | Assumes | a year ago |
Altimmune IncALT | 1 | Strong Buy | $35.00 | N/A | Maintains | 2 years ago |
Prelude Therapeutics IncPRLD | 1 | Strong Buy | $9.00 | N/A | Initiates Coverage On | 2 years ago |
Cytomx Therapeutics IncCTMX | 1 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Kura Oncology IncKURA | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 2 years ago |
Aadi Bioscience IncAADI | 1 | Strong Buy | $675.00 | N/A | Initiates Coverage On | 2 years ago |
Corvus Pharmaceuticals IncCRVS | 1 | Strong Buy | $8.00 | N/A | Initiates Coverage On | 2 years ago |
Glycomimetics IncGLYC | 1 | Strong Buy | $4.00 | N/A | Upgrades | 2 years ago |
Atreca IncBCEL | 1 | Strong Buy | $30.00 | N/A | Initiates Coverage On | 3 years ago |
Molecular Templates IncMTEM | 1 | Strong Buy | $315.00 | N/A | Initiates Coverage On | 4 years ago |
Sutro Biopharma IncSTRO | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.